Cost ‐effectiveness of testosterone treatment utilising individual patient data from randomised controlled trials in men with low testosterone levels

Conclusions and future researchOur data suggest that testosterone is cost-effective in men<75 years when Beck depression index-derived quality-adjusted life years data are considered; cost-effectiveness in men>75 years is dependent on cardiovascular safety. However, more robust and longer-term cost-utility data are needed to verify our conclusion.

Source: Andrology - January 18, 2024 Category: Urology & Nephrology Authors: Rodolfo Hern ández, Nipun Lakshitha de Silva, Jemma Hudson, Moira Cruickshank, Richard Quinton, Paul Manson, Waljit S. Dhillo, Siladitya Bhattacharya, Miriam Brazzelli, Channa N. Jayasena Tags: ORIGINAL ARTICLE Source Type: research